Literature DB >> 18624686

Butenafine and superficial mycoses: current status.

Archana Singal1.   

Abstract

BACKGROUND: Butenafine hydrochloride, a benzylamine derivative, exhibits potent fungicidal activity particularly against dermatophytes, aspergilli, dimorphic and dematiaceous fungi.
OBJECTIVE: To review pharmacokinetics, mechanism of actions and clinical efficacy of butenafine against various dermatophytic and other superficial fungal infections.
METHODS: Medline search was made using keyword butenafine. All English language articles were considered for this review. For inclusion in clinical efficacy section when ever available randomized controlled trials were considered a priority over other trials. RESULTS/
CONCLUSIONS: The drug has excellent penetration into the epidermis and a prolonged retention time following topical application, conferring residual therapeutic activity after treatment cessation. Butenafine possess anti-inflammatory activity too. Topical butenafine 1% cream has been reported to be efficacious for tinea pedis, tinea corporis and tinea cruris in many randomized clinical trials when used for shorter duration. Its efficacy against pityriasis versicolor, seborrheic dermatitis and as anticandidal agent is not yet fully established.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624686     DOI: 10.1517/17425255.4.7.999

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  6 in total

1.  Anti-dermatophytic activity of marine sponge, Sigmadocia carnosa (Dendy) on clinically isolated fungi.

Authors:  N B Dhayanithi; T T Ajith Kumar; M Kalaiselvam; T Balasubramanian; N Sivakumar
Journal:  Asian Pac J Trop Biomed       Date:  2012-08

Review 2.  Newer Topical Treatments in Skin and Nail Dermatophyte Infections.

Authors:  Kanika Sahni; Sanjay Singh; Sunil Dogra
Journal:  Indian Dermatol Online J       Date:  2018 May-Jun

3.  Structural Similarities between Some Common Fluorophores Used in Biology, Marketed Drugs, Endogenous Metabolites, and Natural Products.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  Mar Drugs       Date:  2020-11-23       Impact factor: 5.118

Review 4.  Treatment of superficial mycoses: review. Part II.

Authors:  Maria Fernanda Reis Gavazzoni Dias; Fred Bernardes-Filho; Maria Victória Pinto Quaresma-Santos; Adriana Gutstein da Fonseca Amorim; Regina Casz Schechtman; David Rubem Azulay
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

5.  Clinical, epidemiological, and therapeutic profile of dermatophytosis.

Authors:  Carla Andréa Avelar Pires; Natasha Ferreira Santos da Cruz; Amanda Monteiro Lobato; Priscila Oliveira de Sousa; Francisca Regina Oliveira Carneiro; Alena Margareth Darwich Mendes
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

Review 6.  Luliconazole for the treatment of fungal infections: an evidence-based review.

Authors:  Deepshikha Khanna; Subhash Bharti
Journal:  Core Evid       Date:  2014-09-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.